First National Trust CO Pfizer Inc Transaction History

First National Trust CO

$2.56 Billion
Q3 2024

A detailed history of First National Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, First National Trust CO holds 76,056 shares of PFE stock, worth $2.09 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

76,056

Previous 80,601 5.64%

Holding current value

$2.09 Million

Previous $2.26 Million 2.39%

% of portfolio

0.09%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $125,896 - $142,667	-4,545 Reduced 5.64%	76,056 $2.2 Million
Q2 2024 Aug 02, 2024	SELL	$25.26 - $29.6 $153,454 - $179,820	-6,075 Reduced 7.01%	80,601 $2.26 Million
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $344,854 - $396,003	-13,320 Reduced 13.32%	86,676 $2.41 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $106,741 - $138,644	-4,085 Reduced 3.92%	99,996 $2.88 Million
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $288,745 - $337,514	-8,998 Reduced 7.96%	104,081 $3.45 Million
Q2 2023 Aug 01, 2023	SELL	$36.12 - $41.79 $204,764 - $236,907	-5,669 Reduced 4.77%	113,079 $4.15 Million
Q1 2023 Apr 26, 2023	SELL	$39.39 - $51.28 $146,727 - $191,018	-3,725 Reduced 3.04%	118,748 $4.84 Million
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $7,097 - $9,265	-170 Reduced 0.14%	122,473 $6.28 Million
Q3 2022 Nov 02, 2022	SELL	$43.76 - $53.42 $16,978 - $20,726	-388 Reduced 0.32%	122,643 $5.37 Million
Q2 2022 Aug 03, 2022	SELL	$46.53 - $55.17 $68,306 - $80,989	-1,468 Reduced 1.18%	123,031 $6.45 Million
Q1 2022 May 03, 2022	SELL	$45.75 - $56.69 $115,015 - $142,518	-2,514 Reduced 1.98%	124,499 $6.45 Million
Q4 2021 Feb 03, 2022	BUY	$41.32 - $61.25 $378,491 - $561,050	9,160 Added 7.77%	127,013 $7.5 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $158,962 - $204,201	-4,050 Reduced 3.32%	117,853 $5.07 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $401,437 - $454,761	-11,179 Reduced 8.4%	121,903 $4.77 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $1.13 Million - $1.28 Million	-33,787 Reduced 20.25%	133,082 $4.82 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $458,271 - $582,731	-13,692 Reduced 7.58%	166,869 $6.14 Million
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $43,815 - $51,405	-1,380 Reduced 0.76%	180,561 $6.63 Million
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $8,734 - $10,596	-290 Reduced 0.16%	181,941 $5.95 Million
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $53,330 - $76,197	-1,973 Reduced 1.07%	182,231 $5.95 Million
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $220,300 - $250,013	6,692 Added 3.77%	184,204 $7.22 Million
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $111,863 - $145,053	3,443 Added 1.98%	177,512 $6.38 Million
Q2 2019 Jul 22, 2019	BUY	$36.98 - $41.52 $526,040 - $590,622	14,225 Added 8.9%	174,069 $7.54 Million
Q1 2019 Apr 25, 2019	BUY	$37.5 - $41.2 $318,487 - $349,911	8,493 Added 5.61%	159,844 $6.79 Million
Q4 2018 Jan 28, 2019	BUY	$38.47 - $43.86 $305,490 - $348,292	7,941 Added 5.54%	151,351 $6.61 Million
Q3 2018 Oct 31, 2018	BUY	$34.47 - $41.81 $478,064 - $579,862	13,869 Added 10.71%	143,410 $0
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $168,956 - $180,124	-5,123 Reduced 3.8%	129,541 $4.7 Million
Q1 2018 Apr 30, 2018	SELL	$31.91 - $37.02 $1.23 Million - $1.42 Million	-38,428 Reduced 22.2%	134,664 $4.78 Million
Q4 2017 Jan 17, 2018	BUY	$33.26 - $35.29 $338,985 - $359,675	10,192 Added 6.26%	173,092 $6.27 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $262,384 - $289,045	8,464 Added 5.48%	162,900 $5.82 Million
Q2 2017 Aug 07, 2017	BUY	N/A	154,436	154,436 $5.19 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First National Trust CO with notifications on news.

Account

First National Trust CO Pfizer Inc Transaction History